Entering text into the input field will update the search result below

More on Neuralstem Q2 results

Aug. 08, 2014 9:25 AM ETPalisade Bio, Inc. (PALI) StockBy: Douglas W. House, SA News Editor4 Comments
  • Neuralstem (CUR) Q2 results: Revenues: $5.0M (+100.0%); Operating Expenses: $3.5M (+8.6%); Operating Loss: ($3.5M) (-8.5%); Net Loss: ($6.8M) (-8.0%); Loss Per Share: ($0.08) (+11.1%); Quick Assets: $30.2M (+79.8%).
  • No guidance given.

Recommended For You

About PALI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PALI--
Palisade Bio, Inc.